No abstract available
Publication types
-
Case Reports
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adrenergic Uptake Inhibitors / adverse effects
-
Adrenergic Uptake Inhibitors / pharmacokinetics
-
Adrenergic Uptake Inhibitors / therapeutic use
-
Antidepressive Agents / adverse effects*
-
Antidepressive Agents / pharmacokinetics
-
Antidepressive Agents / therapeutic use
-
Antineoplastic Agents, Hormonal / adverse effects*
-
Antineoplastic Agents, Hormonal / pharmacokinetics
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Biotransformation / genetics
-
Breast Neoplasms / blood
-
Breast Neoplasms / drug therapy*
-
Breast Neoplasms / psychology
-
Carcinoma, Ductal, Breast / blood
-
Carcinoma, Ductal, Breast / drug therapy*
-
Carcinoma, Ductal, Breast / psychology
-
Cyclohexanols / adverse effects
-
Cyclohexanols / pharmacokinetics
-
Cyclohexanols / therapeutic use
-
Cytochrome P-450 CYP2D6 / genetics
-
Cytochrome P-450 CYP2D6 Inhibitors
-
Delayed-Action Preparations
-
Depressive Disorder, Major / blood
-
Depressive Disorder, Major / drug therapy*
-
Drug Interactions / genetics
-
Drug Therapy, Combination
-
Female
-
Genotype
-
Hot Flashes / blood
-
Hot Flashes / chemically induced
-
Hot Flashes / drug therapy
-
Hot Flashes / psychology
-
Humans
-
Middle Aged
-
Pharmacogenetics*
-
Selective Serotonin Reuptake Inhibitors / adverse effects
-
Selective Serotonin Reuptake Inhibitors / pharmacokinetics
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Tamoxifen / adverse effects*
-
Tamoxifen / analogs & derivatives
-
Tamoxifen / blood
-
Tamoxifen / pharmacokinetics
-
Tamoxifen / therapeutic use
-
Treatment Outcome
-
Venlafaxine Hydrochloride
Substances
-
Adrenergic Uptake Inhibitors
-
Antidepressive Agents
-
Antineoplastic Agents, Hormonal
-
Cyclohexanols
-
Cytochrome P-450 CYP2D6 Inhibitors
-
Delayed-Action Preparations
-
Serotonin Uptake Inhibitors
-
Tamoxifen
-
4-hydroxy-N-desmethyltamoxifen
-
Venlafaxine Hydrochloride
-
Cytochrome P-450 CYP2D6